Neural reward circuit dysfunction as a risk factor for bipolar spectrum disorders and substance use disorders: A review and integration

2021 ◽  
pp. 102035
Author(s):  
Corinne P. Bart ◽  
Madison K. Titone ◽  
Tommy H. Ng ◽  
Robin Nusslock ◽  
Lauren B. Alloy
2013 ◽  
Vol 52 (10) ◽  
pp. 1026-1037 ◽  
Author(s):  
Benjamin I. Goldstein ◽  
Michael Strober ◽  
David Axelson ◽  
Tina R. Goldstein ◽  
Mary Kay Gill ◽  
...  

2008 ◽  
Vol 10 (4) ◽  
pp. 469-478 ◽  
Author(s):  
Benjamin I Goldstein ◽  
Michael A Strober ◽  
Boris Birmaher ◽  
David A Axelson ◽  
Christianne Esposito-Smythers ◽  
...  

2016 ◽  
Vol 21 ◽  
pp. 33-36 ◽  
Author(s):  
Debasish Basu ◽  
Bhagyalakshmi Nanjayya Subodh ◽  
Kavita Nagpal ◽  
Sudhir Mahajan

CNS Spectrums ◽  
2010 ◽  
Vol 15 (2) ◽  
pp. 95-109 ◽  
Author(s):  
Icro Maremmani ◽  
Matteo Pacini ◽  
Francesco Lamanna ◽  
Pier Paolo Pani ◽  
Giulio Perugi ◽  
...  

ABSTRACTIndividuals suffering from drug addiction may also manifest features of bipolar spectrum disorders. Hyperthymic and cyclothymic temperaments may render individuals vulnerable to later development of substance abuse. Bipolar disorders themselves may be altered or precipitated by substance use, most notably by stimulants (amphetamines), alcohol, and cannabinoids.The clinical usefulness of mood stabilizers, particularly antiepileptics, has been established as safe and effective in substance abusers with and without comorbid mood disorders. Most studies on this issue have been of short duration and focused on the resolution of a currently manifest period of illness. Few studies have been conducted on the usefulness of these drugs on the long-term longitudinal course of these diseases, such as frequently encountered recurrent relapses into states of agitation, impulsivity, and/or dissatisfaction. As opposed to the clinical experience with traditional antidepressants and neuroleptics, antiepileptics do not induce counter-polar states (depressed patients abruptly turning manic or hypomanic; nor patients currently hypomanic or manic turning abruptly depressed). Many clinicians consider antiepileptic mood stabilizers to be the preferred category of medications for the treatment of such patients. Valproate appears to be a potentially fruitful medication to study in these dual diagnosis patients due to preliminary evidence demonstrating its anticraving efficacy.


2019 ◽  
Author(s):  
Sarah Havens Sperry ◽  
Molly A. Walsh ◽  
Thomas Richard Kwapil

Introduction: Altered emotion dynamics may represent a transdiagnostic risk factor for mood psychopathology. The present study examined whether altered emotion dynamics were associated with bipolar and depressive psychopathology concurrently and at a three-year follow-up. Methods: At baseline (n=138), participants completed diagnostic interviews, questionnaires, and seven days of experience sampling assessments. Four emotion dynamics were computed for negative affect (NA) and positive affect (PA) – within-person variance (variability), mean square of successive differences and probability of acute change (instability), and autocorrelation (inertia). At the three-year follow-up, participants (n=108) were re-assessed via interviews and questionnaires. Results: NA variability was associated with bipolar spectrum disorders at baseline and follow-up. NA instability predicted depressive symptoms and hypomanic personality at baseline, and bipolar spectrum disorders at the follow-up. NA inertia did not predict diagnoses or symptoms at either assessment. PA inertia predicted hyperthymic temperament at baseline but not follow-up. Notably, NA variability and instability predicted the development of new bipolar spectrum disorders at the follow-up. Limitations: Consistent with the recruitment strategy and young age of the participants, only 50% had developed diagnosable psychopathology by the time of the follow-up assessment. Conclusions: The present study provided a unique demonstration that altered emotion dynamics differentially predicted bipolar and depressive psychopathology concurrently and prospectively. Emotion dynamics are important to both digital phenotyping and mobile-based interventions as emotional instability offers a measurable risk factor that is identifiable prior to illness onset.


2002 ◽  
Vol 27 (6) ◽  
pp. 15-29 ◽  
Author(s):  
Sarah Mynatt ◽  
Patricia Cunningham ◽  
J. Sloan Manning

Sign in / Sign up

Export Citation Format

Share Document